A case of autoimmune pulmonary alveolar proteinosis responding to oral statin therapy

Autor: So Shimamura, Honami Morikawa, Ken Shinohara, Hiroki Ohkoshi, Chisa Omori, Yuuki Hoshino, Yoshinori Uchida, Saiki Masafumi, Shinnosuke Ikemura, Naoki Ohishi, Tetsuo Kondo, Kenzo Soejima
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Respiratory Medicine Case Reports, Vol 50, Iss , Pp 102042- (2024)
Druh dokumentu: article
ISSN: 2213-0071
DOI: 10.1016/j.rmcr.2024.102042
Popis: There is no approved drug treatment for autoimmune pulmonary alveolar proteinosis (APAP), although traditionally requires complex treatments such as whole lung lavage (WLL). We herein report on a 67-year-old man diagnosed with APAP. Treatment with atorvastatin (5 mg daily) resulted in significant improvement in symptoms, lung function, and computed tomography findings, with enhanced oxygenation, although serum anti-GM-CSF antibody levels remained elevated. This case suggests that the remission observed in this case could potentially be attributed to a direct effect of atorvastatin within the pulmonary alveoli. Statins may be considered as one of the treatment options for APAP.
Databáze: Directory of Open Access Journals